Gunst J, Gohil J, Li J, Bosch R, White Catherine Seamon A, Chun T
Nat Commun. 2025; 16(1):906.
PMID: 39837813
PMC: 11751076.
DOI: 10.1038/s41467-025-56116-1.
Dube K, Villa T, Freshwater W, Mauk B, Rid A, Peluso M
J Virus Erad. 2024; 10(3):100386.
PMID: 39364082
PMC: 11447310.
DOI: 10.1016/j.jve.2024.100386.
Rennie S, Henderson G, Phanuphak N, Kuczynski K, Colby D, Ormsby N
Ethics Hum Res. 2023; 45(4):2-15.
PMID: 37368521
PMC: 11401446.
DOI: 10.1002/eahr.500172.
Dube K, Morton T, Fox L, Dee L, Palm D, Villa T
Lancet Infect Dis. 2023; 23(10):e418-e430.
PMID: 37295453
PMC: 10543569.
DOI: 10.1016/S1473-3099(23)00267-0.
Lamptey H, Newcomb B, Bonney E, Aboagye J, Puplampu P, Ganu V
AIDS Res Treat. 2023; 2023:8158439.
PMID: 37292229
PMC: 10247315.
DOI: 10.1155/2023/8158439.
HIV cure: an acceptability scientific agenda.
Bonney E, Lamptey H, Kyei G
Curr Opin HIV AIDS. 2022; 18(1):12-17.
PMID: 36503877
PMC: 9757853.
DOI: 10.1097/COH.0000000000000771.
"It comes altogether as one:" perceptions of analytical treatment interruptions and partner protections among racial, ethnic, sex and gender diverse HIV serodifferent couples in the United States.
Campbell D, Dube K, Cowlings P, Dionicio P, Tam R, Agarwal H
BMC Public Health. 2022; 22(1):1317.
PMID: 35810288
PMC: 9270765.
DOI: 10.1186/s12889-022-13528-8.
Perceptions of HIV cure and willingness to participate in HIV cure-related trials among people enrolled in the Netherlands cohort study on acute HIV infection.
van Paassen P, Dijkstra M, Peay H, Rokx C, Verbon A, Reiss P
J Virus Erad. 2022; 8(2):100072.
PMID: 35769632
PMC: 9234345.
DOI: 10.1016/j.jve.2022.100072.
Participant Perspectives and Experiences Following an Intensively Monitored Antiretroviral Pause in the United States: Results from the AIDS Clinical Trials Group A5345 Biomarker Study.
Dube K, Eskaf S, Barr L, Palm D, Hogg E, Simoni J
AIDS Res Hum Retroviruses. 2022; 38(6):510-517.
PMID: 35323030
PMC: 9225827.
DOI: 10.1089/AID.2021.0170.
Preliminary Acceptability of a Home-Based Peripheral Blood Collection Device for Viral Load Testing in the Context of Analytical Treatment Interruptions in HIV Cure Trials: Results from a Nationwide Survey in the United States.
Dube K, Eskaf S, Hastie E, Agarwal H, Henley L, Roebuck C
J Pers Med. 2022; 12(2).
PMID: 35207719
PMC: 8879991.
DOI: 10.3390/jpm12020231.
Balancing Statistical Power and Risk in HIV Cure Clinical Trial Design.
Lau J, Cromer D, Pinkevych M, Lewin S, Rasmussen T, McMahon J
J Infect Dis. 2022; 226(2):236-245.
PMID: 35104873
PMC: 9400422.
DOI: 10.1093/infdis/jiac032.
Attitudes About Analytic Treatment Interruption (ATI) in HIV Remission Trials with Different Antiretroviral Therapy (ART) Resumption Criteria.
Peay H, Rennie S, Cadigan R, Gwaltney A, Jupimai T, Phanuphak N
AIDS Behav. 2022; 26(5):1504-1516.
PMID: 34997386
PMC: 9007833.
DOI: 10.1007/s10461-021-03504-5.
Ethics of HIV cure research: an unfinished agenda.
Dube K, Kanazawa J, Taylor J, Dee L, Jones N, Roebuck C
BMC Med Ethics. 2021; 22(1):83.
PMID: 34193141
PMC: 8243312.
DOI: 10.1186/s12910-021-00651-1.
Considerations for Increasing Racial, Ethnic, Gender, and Sexual Diversity in HIV Cure-Related Research with Analytical Treatment Interruptions: A Qualitative Inquiry.
Dube K, Kanazawa J, Campbell C, Boone C, Maragh-Bass A, Campbell D
AIDS Res Hum Retroviruses. 2021; 38(1):50-63.
PMID: 33947268
PMC: 8785755.
DOI: 10.1089/AID.2021.0023.
Ethical and practical considerations for mitigating risks to sexual partners during analytical treatment interruptions in HIV cure-related research.
Dube K, Kanazawa J, Dee L, Taylor J, Campbell D, Brown B
HIV Res Clin Pract. 2021; 22(1):14-30.
PMID: 33757411
PMC: 8272285.
DOI: 10.1080/25787489.2021.1902116.
Motivations, barriers and experiences of participants in an HIV reservoir trial.
De Scheerder M, van Bilsen W, Dullaers M, Martinez-Picado J, Davidovich U, Vandekerckhove L
J Virus Erad. 2021; 7(1):100029.
PMID: 33598311
PMC: 7868726.
DOI: 10.1016/j.jve.2021.100029.
Heightened resistance to host type 1 interferons characterizes HIV-1 at transmission and after antiretroviral therapy interruption.
Gondim M, Sherrill-Mix S, Bibollet-Ruche F, Russell R, Trimboli S, Smith A
Sci Transl Med. 2021; 13(576).
PMID: 33441429
PMC: 7923595.
DOI: 10.1126/scitranslmed.abd8179.
Framing a Consent Form to Improve Consent Understanding and Determine How This Affects Willingness to Participate in HIV Cure Research: An Experimental Survey Study.
Sauceda J, Dube K, Brown B, Perez A, Rivas C, Evans D
J Empir Res Hum Res Ethics. 2020; 16(1-2):78-87.
PMID: 33307932
PMC: 8035136.
DOI: 10.1177/1556264620981205.
A landscape analysis of HIV cure-related clinical research in 2019.
Barr L, Jefferys R
J Virus Erad. 2020; 6(4):100010.
PMID: 33294212
PMC: 7695817.
DOI: 10.1016/j.jve.2020.100010.
Initiation of Antiretroviral Therapy during Primary HIV Infection: Effects on the Latent HIV Reservoir, Including on Analytic Treatment Interruptions.
Shelton E, Reeves D, Bender Ignacio R
AIDS Rev. 2020; 23(1):28-39.
PMID: 33105471
PMC: 7987773.
DOI: 10.24875/AIDSRev.20000001.
